I really beg to differ. Company keeps diluting at 50% off market while paying CEO for cars, trips, homes, etc......without a dime. I can understand 5 years in development, or maybe 7 - this is NOT a bioTECH company, so you don't get a 15 year science project, ZERO revenues, $25M in capital raises, and a product that has yet t be demonstrated. All I see from this company is massive shareholder dilution, regurgitated press releases about the "market" and NOTHING about its products, and a complete failure by most of those here, to simply conduct basic DD based on disclosures signed by the CEO herself. You are riding on air here, nothing more. And those shareholders down under may hit the ground very hard soon.